Skip to content

Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

Acute Proof-of-Concept Study to Evaluate Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06283030
Enrollment
14
Registered
2024-02-28
Start date
2022-01-14
Completion date
2023-05-31
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Sleep Apnea, Obstructive, Sleep Apnea Syndromes, Sleep Disorder

Brief summary

This proof-of-concept study is being performed to evaluate whether the hypoglossal nerve can be stimulated using a small series of electrodes placed surgically via a percutaneous approach. Minimally invasive off the shelf medical devices will be used and observation of the characteristic physiological responses to stimulation of the HGN, will be assessed.

Interventions

Device-mediated stimulation of the hypoglossal nerve

Sponsors

Invicta Medical Inc.
Lead SponsorINDUSTRY
Vanderbilt University Medical Center
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Subject must be eligible for an OSA diagnostic or surgical procedure. * Subject suffers with moderate to severe OSA based on history and a physical exam. * Subject has failed, refused or has not tolerated CPAP treatment. * Subject is willing and capable of providing informed consent. * Subject is willing to have a representative electrode array temporarily placed in the submandibular, sublingual and mylohyoid space. --Subject is willing to participate in the designated follow-up visits. * Subject must be in good general health. * Subject is able to understand and has voluntarily signed and dated the IRB or EC approved informed consent form (ICF) prior to initiation of any screening or study-specific procedure. * Subject must be minimum of 21 years and maximum 80 years of age. * Subject's Hypoglossal Nerve must be able to be visualized using ultrasound

Exclusion criteria

* Subject has Body Mass Index above 38kg/m2. * Subject has had surgical resection or radiation therapy for cancer or congenital malformations in the larynx, tongue, or throat. * Subject has significant co-morbidities making them unable or inappropriate to participate in this POC study. * Subject plans to become pregnant, is currently pregnant or breastfeeding during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Identification and access of the target outcomesDay 0Consistent identification of and access to the target stimulation location aligned with the medial branch of the Hypoglossal Nerve.
Tongue protrusion outcomesDay 0Visual verification of protrusion of the tongue during stimulation at the target stimulation location with a representative electrode array.
Characterization of electrode array outcomesDay 0Spatial characterization of the orientation of the electrode array and lead body to the target stimulation location considering suitable chronic anchoring locations.
Electrode array placement and removal outcomesDay 0To demonstrate the ability to safely place and remove the electrode array, per protocol instructions.
Safety outcomesDay 30To evaluate and report all observed adverse events, serious adverse events, unanticipated adverse events and adverse device effects observed during the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026